183 |
Factors Associated With Neurocognitive Impairment Following Chemoradiotherapy in Patients With High-Grade Glioma: Results of a Prospective TrialFactors Associated With Neurocognitive Impairment Following Chemoradiotherapy in Patients With High-Grade Glioma: Results of a Prospective Trial
Prashasti Sharma, Partha Pratim Medhi, Apurba Kumar Kalita, Mouchumee Bhattacharyya, Jyotiman Nath, Gautam Sarma, Yanpothung YanthanPrashasti Sharma, Partha Pratim Medhi, Apurba Kumar Kalita, Mouchumee Bhattacharyya, Jyotiman Nath, Gautam Sarma, Yanpothung Yanthan
KMSID: 1516083461 Brain Tumor Res Treat. 2023;11(3):183-190. Published online 2023 July 31 DOI: http://dx.doi.org/10.14791/btrt.2023.0004 |
191 |
Comparing the Expression of Canonical and Non-Canonical Inflammasomes Across Glioma Grades: Evaluating Their Potential as an Aggressiveness MarkerComparing the Expression of Canonical and Non-Canonical Inflammasomes Across Glioma Grades: Evaluating Their Potential as an Aggressiveness Marker
Yu Jin Kim, Wooseok Choi, JeongMin Sim, Ju Won Ahn, JeongMan Park, Dongkil Kim, Ju-Yeon Jeong, Ji Min Lee, Kyunggi Cho, Jong-Seok Moon, Ju Hyung Moon, Kyoung Su Sung, Jaejoon LimYu Jin Kim, Wooseok Choi, JeongMin Sim, Ju Won Ahn, JeongMan Park, Dongkil Kim, Ju-Yeon Jeong, Ji Min Lee, Kyunggi Cho, Jong-Seok Moon, Ju Hyung Moon, Kyoung Su Sung, Jaejoon Lim
KMSID: 1516083465 Brain Tumor Res Treat. 2023;11(3):191-203. Published online 2023 July 31 DOI: http://dx.doi.org/10.14791/btrt.2023.0008 |